Induction erlotinib or gemcitabine/carboplatin factorial assignment therapy in stage IIIA-N2 non-small cell lung cancer.
W. Zhong
No relevant relationships to disclose
X. Yang
No relevant relationships to disclose
R. Liao
No relevant relationships to disclose
Q. Nie
No relevant relationships to disclose
S. Dong
No relevant relationships to disclose
J. Su
No relevant relationships to disclose
X. Zhang
No relevant relationships to disclose
Q. Zhou
No relevant relationships to disclose
J. Yang
No relevant relationships to disclose
Y. L. Wu
No relevant relationships to disclose